The FDA Law Blog

MARCH 8, 2023

By Véronique Li, Senior Medical Device Regulation Expert — On March 17, 2023, enhancements to FDA’s electronic Medical Device Reporting (eMDR) system will go live. Manufacturers who submit reports via the FDA Electronic Submissions Gateway are being advised to update their systems by this time. b)(1)(iii).

Packaging 59

Packaging FDA Communication 59

The FDA Law Blog

OCTOBER 5, 2022

By Riëtte van Laack — On September 28, 2022, FDA announced the availability of the proposed rule for the implied nutrient content claim “healthy.” The term healthy, as an implied nutrient claim, was first defined by FDA in 1994. FDA also announced it would be re-evaluating the regulatory criteria for use of the “healthy” claim.

FDA 52

FDA Labelling Packaging Documentation 52

pharmaphorum

APRIL 9, 2021

Back in 2015, AZ built the first partnership with these companies through the acquisition of the rights to develop and commercialise monalizumab, our lead assay targeting NKG2A,” says Mahjoubi. “The The idea is to prepare the preclinical package to start clinical development,” says Mahjoubi.

Immunization 122

Immunization Packaging FDA 122

The Checkup by Singlecare

JANUARY 18, 2024

Start by reading the package insert, and ask your pharmacist questions if there’s anything you don’t understand. It’s essential that your healthcare provider know everything that you are taking before they prescribe Bactrim, as it can have interactions. Follow the instructions on your prescription label. Stay hydrated.

Mayo Clinic 105

Mayo Clinic Adverse Reactions Packaging Labelling 105

The Checkup by Singlecare

JANUARY 4, 2024

Always follow the directions on the packaging or consult a healthcare professional if you have concerns about the appropriate dosage. In addition, the FDA label for the nighttime forms of Mucinex containing acetaminophen recommends avoiding three or more drinks per day.

Immunization 102

Immunization Labelling Dosage Medication Labelling 102

Pharmaceutical Technology

OCTOBER 25, 2022

Pharmaceutical companies – and the FDA – are embracing FDCs. From 1990 through 2013, the FDA approved 131 FDC products, on average 5.7 From 1990 through 2013, the FDA approved 131 FDC products, on average 5.7 Between 2010 and the end of 2015, of the 655 New Drug Applications (NDAs) approved by the FDA, 63 were for FDCs.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Dosage Packaging 52

DiversifyRx

JULY 11, 2024

Small Dispensers and the 6/12/2024 FDA Announcement Concerning DSCSA This week’s article on the recent DSCSA postponement comes from PRS Pharmacy Services. If the FDA or another regulator requests DSCSA transaction data, the DSCSA regulations give you up to 48 hours to respond. The original article can be found HERE.

Independent Pharmacies 52

Independent Pharmacies FDA Documentation CPhT 52

The Checkup by Singlecare

FEBRUARY 16, 2024

“Antioxidant” has become a hyper-common wellness buzzword, slapped on health food packages so often that many people don’t think twice about it. The Food and Drug Administration (FDA) has approved it as a treatment for acetaminophen overdose. But it’s not just a long-term treatment.

Immunization 83

Immunization Dosage Packaging FDA 83

Pharmacy Friday Pearls

MARCH 9, 2022

It is important to note that at present, Anavip ® is only FDA approved for North American rattlesnake envenomations, even though it is expected that it is safe and effective to use for copperhead and water moccasin envenomations as well. Crofab ® [package insert]. Anavip ® [package insert]. in the treatment group vs 7.4

Immunization 40

Immunization Packaging Labelling FDA 40

pharmaphorum

AUGUST 25, 2021

It’s now globally accessible due to Gilead’s work with a network of generic manufacturers and their ability to sign licensing agreements just days after the US FDA registered its authorisation. In 2015, PEPFAR reached out to Gilead and said they were working with the government in Sub-Saharan Africa. Laying the groundwork.

Packaging 52

Packaging Compounding FDA Labelling 52

European Pharmaceutical Review

FEBRUARY 14, 2024

The first drug products to achieve biological licence approval (BLA) from the US Food and Drug Administration (FDA) are whole community products derived from human faecal matter and are indicted for Clostridium difficile infection. 2015; 69(1):381–403 5. Leveraging Quorum Sensing to Manipulate Microbial Dynamics. 2021; 19:100306 4.

Dosage 97

Dosage Packaging Compounding Labelling 97

ISPE

MAY 11, 2023

The FDA, PIC/S, and WHO have all emphasized the importance and benefits of data flows in their guidance on data integrity. The goal is to break down complex processes into easy-to-grasp packages, including data privacy and information technology (IT) security. April 2015. Methodology to Define a Pharma 4.0™ to Industry 4.0

Packaging 52

Packaging Documentation Communication Data Entry 52

pharmaphorum

JUNE 1, 2021

Many countries have introduced serialisation legislation which requires product identifiers to be affixed to each package to provide traceability throughout the distribution supply chain. However, traceability and security measures focused on the packaging level may not be enough to protect patients.

Packaging 52

Packaging Dosage Pharmaceutical Companies Pharmaceutical Companies 52

ISPE

MARCH 8, 2023

Identification and Analysis of Contamination Trends Three major recall databases—those of the US FDA, the United Kingdom’s Medicine and Healthcare Products Regulatory Agency (UK MHRA), and Australia’s Therapeutic Goods Administration (TGA)—were searched to assess contamination trends in the past five years.

Compounding 52

Compounding Compounding Pharmacies Packaging FDA 52

Pharmacy Friday Pearls

SEPTEMBER 23, 2022

Four factor prothrombin complex concentrate (4F-PCC) is FDA approved to reverse vitamin K antagonists (VKAs) such as warfarin in adult patients with acute major bleeding or a need for an urgent surgery/invasive procedure. Dosing According to Package Insert. Kcentra (prothrombin complex concentrate [Human]) [package insert].

Packaging 40

Packaging Hospitals FDA 40

The Checkup by Singlecare

SEPTEMBER 28, 2023

Follow these steps to try nasal irrigation for congestion: Prepare the nasal rinse solution by mixing saline with distilled water per the package instructions. The FDA recently announced that the oral version of phenylephrine, a popular ingredient in some decongestants, is ineffective.

Compounding 105

Compounding Immunization Mayo Clinic Dosage 105

The Checkup by Singlecare

DECEMBER 26, 2023

A supplement package may claim it contains lion’s mane mushroom, but it may not specify what part of the mushroom it’s made from. Food and Drug Administration (FDA) does not regulate nutritional supplements in the same way that it regulates medications. Dr. Cooperman explains. Fr) Pers.

Immunization 52

Immunization Dosage Packaging FDA 52

European Pharmaceutical Review

AUGUST 10, 2023

Amidst numerous warning letters distributed by the US Food and Drug Administration (FDA) to pharmaceutical manufacturers in recent months, in July this year, the US regulatory body published its analysis on drug product quality in 2022. Eight FDA warning letters were handed to European companies in 2018. Edge Biologicals Inc.,

FDA 98

FDA Packaging 98

Pharmaceutical Technology

MARCH 30, 2023

On March 29, the US Food and Drug Administration (FDA) granted approval for the first nonprescription, “over-the-counter” (OTC) naloxone nasal spray, Narcan. The FDA also has an Overdose Prevention Framework that aligns with this national strategy. The FDA first approved Narcan 4mg nasal spray as a prescription drug in 2015.

FDA 52

FDA Packaging 52

The Thyroid Pharmacist

JULY 29, 2022

This article of mine discusses 19 thyroid-toxic products that have been banned by the FDA. About 10 percent of those in my 2015 survey of 2,232 people with Hashimoto’s said that mold was a trigger for them… and those were only the ones who had already uncovered the issue. doi:10.1155/2015/760689. 2015 Jan 1;20:872-91.

Health and Personal Care Stores 52

Health and Personal Care Stores Compounding Immunization Labelling 52

ISPE

SEPTEMBER 11, 2023

4 , 5 Additionally, reducing shipping limitations—such as packaging, storage, and transportation durations—helps speed up patient access in certain instances while ensuring there is no negative impact to the product’s critical quality attributes (CQAs). 1 May 2015. Journal of Biotechnology 213 (2015):120–30. 12 April 2016.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

ISPE

SEPTEMBER 11, 2023

Regulatory Background and Cleanroom Air Velocity In 2015, the authors of the Concept Paper on Revision of Annex 1 decided to harmonize the regulatory framework globally, including established methodologies such as those from the International Organization for Standardization (ISO). Published 2 February 2015. At what velocity?

Documentation 52

Documentation FDA Packaging Communication 52

ISPE

JULY 6, 2023

1 , 4 A Retrospective Journey In 2015, Vertex’s Orkambi was the first approved drug produced under a CM process for the treatment of cystic fibrosis. An average of two approved drugs via CM per year since 2015 shows that progress has been slow but steady and that interest in CM and its potential has been sustained.

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Dosage Pharmaceutical Companies Pharmaceutical Companies 52

ISPE

AUGUST 29, 2022

For changes requiring approval before implementation, once the necessary information has been submitted across regions, each health authority must review the data package and documentation based on local requirements. ICH Q12: Implementation Considerations for FDA-Regulated Products Guidance for Industry.” Draft Guidance for Industry.

Documentation 52

Documentation FDA Communication Packaging 52

The Checkup by Singlecare

DECEMBER 1, 2023

Plan B prescribing information shared by the Food and Drug Administration (FDA) lists heavier menstrual bleeding (31%), nausea (14%), lower abdominal pain (13%), fatigue (13%), dizziness (10%), and headache (10%) as the most commonly reported side effects in original clinical trials of Plan B. Plan B can be taken with or without food.

FDA 90

FDA Mayo Clinic Dosage Controlled Substances 90